Yorkshire health firm completes "major" multi-million pound facility expansion

A Yorkshire health company has announced that it has completed a “major” expansion of its test manufacturing facility.

Abingdon Health has expanded its York Biotech facility, meaning that the company now has the capacity to manufacture millions of rapid tests a month.

The expansion came in response to the Covid-19 pandemic, as the company developed antibody tests for the virus.

This is Abingdon Health’s third expansion at York Biotech Campus in the last year, as well as the addition of a manufacturing site in Doncaster, with an investment of £5.5m across the year.

Oliver Gardner, COO at Abingdon Health, commented: “The pandemic has raised awareness for the need for rapid testing across industries, not only for Covid-19.

“The demand for rapid tests will continue to grow across healthcare and areas such as crop production, animal health and farming.

“With the market set to exceed £9bn in the near future, we are well positioned to keep pace with demand.

“The new space at our York headquarters is a vital element in becoming one of the world’s leading rapid diagnostic manufacturers, helping more people every day to receive quick and accurate results.”

Want your business, product or service to be seen regionally and nationally? Bdaily helps you get your story in front of the right audience, every day. Find out how Bdaily can help →

Join more than 55,000 subscribers by signing up to our daily bulletin each morning here.